Clopivaz Special Precautions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Special Precautions

Should not be administered to patients with hematopoietic disorders such as neutropenia or thrombocytopenia, haemorrahgic diathesis or other haemorrhagic disorders associated with a prolonged bleeding time, or conditions with an increased risk of bleeding such as gastrointestinal ulcers, acute cerebral haemorrhage, or several liver dysfunction. Full blood counts should be performed before starting treatment and every 2 weeks during the first 3 months of therapy. If discontinued during this period, a full blood count should be performed within 2 weeks of stopping treatment. Consideration should be given at in stopping the therapy 10-14 days before elective surgery.

clopidogrel

Manufacturer:

Lloyd

Distributor:

InnoGen Pharmaceuticals